PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1985; 78(Suppl 10): 25–28.
PMCID: PMC1289443

Evidence that method of use, dose and duration of treatment with benzoyl peroxide and tetracycline determines response of acne.

Abstract

Treatment of acne prior to referral was recorded retrospectively in 72 patients alleged to have responded inadequately; 60% had used benzoyl peroxide (BP) but most applied it to lesions only. Although 86% had used tetracycline, most did not take it correctly for maximum absorption and took less than 1 g/day. Most patients used both drugs for less than three months. Eight-two patients referred because of inadequate response were treated with: (I) 5% benzoyl peroxide (BP) (23 patients); (II) 5% BP and 0.5 g/day oxytetracycline (OTC) (24 patients); (III) 5% BP and 1 g/day OTC (18 patients); (IV) 5% BP and 1.5 g/day OTC (17 patients). BP was applied incrementally from 30 min up to 8-10 hours daily to the entire area affected and OTC taken as a single morning dose. Median grade of severity (0-10 analogue scale) fell by 2 in Groups I and II (P less than 0.05), by 2.5 in Group III (P less than 0.05) and by 3 in Group IV (P less than 0.05); number of lesions fell by 56% +/- 7% (s.e.), (P less than 0.001) 70% +/- less than 10% (P less than 0.001), 75% +/- 8% (P less than 0.001) and 78% +/- 10% (P less than 0.001) respectively and treatment was well tolerated. Thus, although effective drugs are frequently prescribed in acne, method of use, dose and duration are likely to determine response.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (488K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Burke B, Eady EA, Cunliffe WJ. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol. 1983 Feb;108(2):199–204. [PubMed]
  • Cunliffe WJ, Clayden AD, Gould D, Simpson NB. Acne vulgaris--its aetiology and treatment. A review. Clin Exp Dermatol. 1981 Sep;6(5):461–469. [PubMed]
  • Hubbell CG, Hobbs ER, Rist T, White JW., Jr Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris. Arch Dermatol. 1982 Dec;118(12):989–992. [PubMed]
  • Leyden JJ. Antibiotic resistant acne. Cutis. 1976 Mar;17(3):593–596. [PubMed]
  • Marsden JR, Coburn PR, Marks J, Shuster S. Measurement of the response of psoriasis to short-term application of anthralin. Br J Dermatol. 1983 Aug;109(2):209–218. [PubMed]
  • Mills OH, Jr, Kligman AM. Drugs that are ineffective in the treatment of acne vulgaris. Br J Dermatol. 1983 Mar;108(3):371–374. [PubMed]
  • Neuvonen PJ. Interactions with the absorption of tetracyclines. Drugs. 1976;11(1):45–54. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press